G6PD and hepatocellular carcinoma: In this study, G6PD inhibition or knockdown increased the sensitivity of regorafenib-resistant cells to regorafenib, but G6PD overexpression reduced the sensitivity of drug-sensitive cells to regorafenib, indicating that G6PD derived regorafenib resistance in HCC.